Healthcare & Life Sciences

Holoclara

series-a

Stage

Investors

About

Holoclara develops immunotherapy treatments for autoimmune disorders using nematode-derived molecules with therapeutic properties.

Funding rounds, investor list, and risk signals — unlock with a subscription.